RECRUITING

Connect for Cancer Prevention Study (Connect)

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Background: The National Cancer Institute, part of the National Institutes of Health, has partnered with nine health care systems across the U.S. to establish the Connect for Cancer Prevention Study. While researchers have made important discoveries, there is more to learn to lower the number of people affected by cancer. By taking part in Connect, participants can help researchers learn how the way we live, our genetics, and our health history may affect cancer risk. Objective: To study and better understand the causes of cancer and to find new ways to prevent it. Eligibility: The study will include 200,000 adults who get their health care from a partner health care system, are between 30 and 70 years old at enrollment, and have never had cancer. People remain eligible to join if they have or once had non-melanoma skin cancer, or a condition that may raise cancer risk (such as ductal carcinoma in situ, or DCIS). Design: Eligible recruits can sign up for Connect online by creating an account on MyConnect using their email address or phone number. After creating an account, they will complete the informed consent process. All information shared through MyConnect is secure to protect participant privacy. After joining the study, participants will be asked to answer online health surveys a few times a year, donate samples of blood, urine, and saliva every two to three years, and safely share access to their electronic health records with Connect. In the future, participants may donate unused samples that are collected at clinical visits, like tissue, stool, or blood, and may mail in samples collected at home. Participants may also share information from personal health trackers, like wearable devices or apps. This information will help researchers study the health and behavior patterns that may affect cancer risk. It takes time to understand the causes of cancer, so Connect will go on for many years. The longer people participate, the more researchers may learn. Participants can leave the study at any time. Learn more about Connect by visiting cancer.gov/connectstudy.

Official Title

Connect for Cancer Prevention Study: A Prospective Cohort Study Within Integrated Healthcare Systems in the US

Quick Facts

Study Start:2021-07-26
Study Completion:2070-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04609072

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:30 Years to 70 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients or members of participating IHCS at the time of enrollment
  2. * Age between 30 and 70 years old at study invitation
  1. * Individuals with a confirmed history of invasive cancer (other than non-melanoma skin cancer)
  2. * Individuals with known cognitive impairment documented in their medical record

Contacts and Locations

Study Contact

Nicolas A Wentzensen, M.D.
CONTACT
(866) 462-6621
ConnectPI@nih.gov

Principal Investigator

Nicolas A Wentzensen, M.D.
PRINCIPAL_INVESTIGATOR
National Cancer Institute (NCI)

Study Locations (Sites)

Kaiser Permanente Colorado
Denver, Colorado, 80247
United States
Kaiser Permanente Georgia
Atlanta, Georgia, 30305
United States
Kaiser Permanente Hawaii
Honolulu, Hawaii, 96814
United States
University of Chicago Medical Center
Chicago, Illinois, 60603
United States
Henry Ford Health Systems
Detroit, Michigan, 48202
United States
HealthPartners
Minneapolis, Minnesota, 55425
United States
Kaiser Permanente Northwest
Portland, Oregon, 97086
United States
Sanford Health
Sioux Falls, South Dakota, 57117
United States
Baylor Scott and White Health
Dallas, Texas, 75246
United States
Marshfield Clinic Health System
Marshfield, Wisconsin, 54449
United States

Collaborators and Investigators

Sponsor: National Cancer Institute (NCI)

  • Nicolas A Wentzensen, M.D., PRINCIPAL_INVESTIGATOR, National Cancer Institute (NCI)

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-07-26
Study Completion Date2070-12-31

Study Record Updates

Study Start Date2021-07-26
Study Completion Date2070-12-31

Terms related to this study

Keywords Provided by Researchers

  • Risk Factors
  • medical conditions
  • Pathology
  • Blood
  • Urine
  • Natural History

Additional Relevant MeSH Terms

  • Cancer
  • General Research Use